Your browser doesn't support javascript.
loading
Interleukin-17 retinotoxicity is prevented by gene transfer of a soluble interleukin-17 receptor acting as a cytokine blocker: implications for age-related macular degeneration.
Ardeljan, Daniel; Wang, Yujuan; Park, Stanley; Shen, Defen; Chu, Xi Kathy; Yu, Cheng-Rong; Abu-Asab, Mones; Tuo, Jingsheng; Eberhart, Charles G; Olsen, Timothy W; Mullins, Robert F; White, Gary; Wadsworth, Sam; Scaria, Abraham; Chan, Chi-Chao.
Afiliação
  • Ardeljan D; Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Wang Y; Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.
  • Park S; Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America; Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America.
  • Shen D; Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Chu XK; Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Yu CR; Molecular Immunology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Abu-Asab M; Histology Core, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Tuo J; Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Eberhart CG; Department of Pathology, Johns Hopkins University, Baltimore, Maryland, United States of America.
  • Olsen TW; Department of Ophthalmology, Emory University, Atlanta, Georgia, United States of America.
  • Mullins RF; Department of Ophthalmology and Visual Sciences, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States of America.
  • White G; Genzyme Corporation, Framingham, Massachusetts, United States of America.
  • Wadsworth S; Genzyme Corporation, Framingham, Massachusetts, United States of America.
  • Scaria A; Genzyme Corporation, Framingham, Massachusetts, United States of America.
  • Chan CC; Immunopathology Section, Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS One ; 9(4): e95900, 2014.
Article em En | MEDLINE | ID: mdl-24780906
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Retina / Transfecção / Citocinas / Interleucina-17 / Receptores de Interleucina-17 / Degeneração Macular Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Retina / Transfecção / Citocinas / Interleucina-17 / Receptores de Interleucina-17 / Degeneração Macular Limite: Humans Idioma: En Revista: PLoS One Ano de publicação: 2014 Tipo de documento: Article